University of Tasmania
Browse

Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression

journal contribution
posted on 2023-05-21, 14:57 authored by Tao, C, Steve Simpson JRSteve Simpson JR, Bruce TaylorBruce Taylor, Christopher BlizzardChristopher Blizzard, Lucas, R, Ponsonby, AL, Broadley, S, Ingrid van der MeiIngrid van der Mei
<p><strong>Background:</strong>have been implicated in multiple sclerosis (MS) onset but little work has studied their relationships in early disease.</p> <strong>Objectives:</strong>Evaluate associations between markers of EBV and HHV-6 infection/reactivation and MS conversion, relapse and EDSS/MSSS amongst 205 CIS participants with EBV/HHV-6 data followed over 5 years.<p></p> <p><strong>Method:</strong>Baseline serological and viral load measures of EBV and HHV-6 exposure/reactivation were measured and infectious mononucleosis (IM) history recorded. Conversion to MS and relapses were assessed annually, and EDSS/MSSS measured at 5-year review. Determinants of MS conversion and relapse assessed by Cox regression, and disability progression by linear regression.</p> <p><strong>Results:</strong>IM history showed a strong positive trend with higher relapse risk (aHR=1.45,95%CI=0.97-2.16) but was not associated with MS conversion (aHR=0.92,95%CI=0.57-1.48). Anti-HHV-6 IgG titre>40 also showed strong positive trends with higher relapse (aHR=1.61,95%CI=0.99-2.63) and MS conversion risks (aHR=1.48,95%CI=0.89-2.46). Anti-HHV-6 IgG titre≥640 was significantly associated with higher MSSS (0.15(95%CI=0.00,0.30) and also showed a strong positive trend with higher EDSS 0.10(95%CI=-0.02,0.21). HHV-6 DNA detection showed strong positive trends with 83%(95%CI=-6-357) and 77%(95%CI=-4-328) higher MS conversion and relapse risk. Anti-EBV-EA-D IgG titre was associated with a lower annualised disability progression by EDSS (ptrend=0.037) and also showed strong positive trend with higher MSSS (p<sub>trend</sub>=0.053). No associations were seen for other serological or viral load markers.</p> <p><strong>Conclusions:</strong>Overall, our data provides evidence that higher HHV-6 IgG was associated with increased risk of MS conversion and relapse but of borderline significance, and greater annualised disability progression, while that for EBV was more limited.</p>

Funding

National Multiple Sclerosis Society

History

Publication title

Multiple Sclerosis and Related Disorders

Volume

59

Article number

103561

Number

103561

Pagination

1-9

ISSN

2211-0356

Department/School

Menzies Institute for Medical Research

Publisher

Elsevier B. V.

Place of publication

Amsterdam

Rights statement

© 2022 Elsevier B.V.

Socio-economic Objectives

Prevention of human diseases and conditions

Repository Status

  • Restricted

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC